We found that increased recruitment could be attributed to higher CCL22 production by EBVaGC cells, decreased emigration caused by downregulated lymphocyte homing receptor CCR7 on the Treg surface, higher Treg proliferation rates and lower apoptosis rates at tumour sites. The gene discussed is CCL22; the disease is neoplasm.